Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review ; volume:23 ; number:1 ; day:4 ; month:5 ; year:2023 ; pages:1-20 ; date:12.2023
BMC cancer ; 23, Heft 1 (4.5.2023), 1-20, 12.2023
- Creator
-
Heesterman, Berdine L.
Aben, Katja K. H.
Jong, Igle Jan de
Pos, Floris J.
Hel, Olga L. van der
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10842-1
- URN
-
urn:nbn:de:101:1-2023090608434960496649
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heesterman, Berdine L.
- Aben, Katja K. H.
- Jong, Igle Jan de
- Pos, Floris J.
- Hel, Olga L. van der
- SpringerLink (Online service)
Other Objects (12)
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
PTP1B regulates lymphocytes responses androgen deprivation
Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
PTP1B regulates lymphocytes responses androgen deprivation
Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
PTP1B regulates lymphocytes responses androgen deprivation
Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy